Skip to content

CROI: HIV subtype D causes disease more rapidly than HIV-1 subtype A in Uganda

CROI: Rapid scale-up of HIV treatment in Zambia

CROI: Valaciclovir reduces HIV genital shedding in HIV-positive women

CROI: 70% still on first regimen after three years in Khayelitsha, but lactic acidosis a major challenge

CROI: Successful PREP trial in monkeys sparks call for more research

CROI: Insulin resistance common in HIV-positive children

CROI: Simplified treatment regimens show promise in HIV-infected children

Loss of HIV antibodies does not signal HIV clearance, even two years later

Sexual health clinics will struggle to meet 48 hours appointment target, study finds